In an article titled "Trialists: Will Interventional Tx
Tame BP?,"
Reported on a
study that is currently "evaluating renal nerve ablation as a way to curtail"
hypertension. The article also discusses another trial that evaluated the
therapy. "In the nonrandomized Symplicity HTN-1 trial, the percentage of
responders increased over time, reported Paul A. Sobotka, MD, from Ohio State
University in Columbus, at the 2012 American College of Cardiology meeting." The
researchers found that "at one month, 69% of 143 patients responded; at 12
months, it was 79% of 130 patients; at two years, it was 90% of 59 patients; and
at three years, 100% of 24 patients followed for 36 months responded."
WBH
Comment-Approximately 25-30% of Americans are hypertensive. Nearly 10 Million
take 3 or more drugs to treat their hypertension. Renal Denervation may offer
these patients a procedure
that may significantly lower their blood
pressure and need for medications. There are nearly 40 start up companies
currently working on devices to offer this therapy. It should be commerically
available in the US in 2013-2014.
POSTED BY: Steven Almany M.D.
No comments:
Post a Comment